469 related articles for article (PubMed ID: 18606696)
1. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
[TBL] [Abstract][Full Text] [Related]
2. Development of a Novel CD4
Fernandez-Ruiz D; Lau LS; Ghazanfari N; Jones CM; Ng WY; Davey GM; Berthold D; Holz L; Kato Y; Enders MH; Bayarsaikhan G; Hendriks SH; Lansink LIM; Engel JA; Soon MSF; James KR; Cozijnsen A; Mollard V; Uboldi AD; Tonkin CJ; de Koning-Ward TF; Gilson PR; Kaisho T; Haque A; Crabb BS; Carbone FR; McFadden GI; Heath WR
J Immunol; 2017 Dec; 199(12):4165-4179. PubMed ID: 29084838
[TBL] [Abstract][Full Text] [Related]
3. Development of memory CD8+ T cells and their recall responses during blood-stage infection with Plasmodium berghei ANKA.
Miyakoda M; Kimura D; Honma K; Kimura K; Yuda M; Yui K
J Immunol; 2012 Nov; 189(9):4396-404. PubMed ID: 23008449
[TBL] [Abstract][Full Text] [Related]
4. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection.
Ryg-Cornejo V; Nie CQ; Bernard NJ; Lundie RJ; Evans KJ; Crabb BS; Schofield L; Hansen DS
Immunobiology; 2013 Feb; 218(2):263-71. PubMed ID: 22704523
[TBL] [Abstract][Full Text] [Related]
5. Type I interferons contribute to experimental cerebral malaria development in response to sporozoite or blood-stage Plasmodium berghei ANKA.
Palomo J; Fauconnier M; Coquard L; Gilles M; Meme S; Szeremeta F; Fick L; Franetich JF; Jacobs M; Togbe D; Beloeil JC; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2013 Oct; 43(10):2683-95. PubMed ID: 23780878
[TBL] [Abstract][Full Text] [Related]
6. Activation and exhaustion of antigen-specific CD8
Bayarsaikhan G; Miyakoda M; Yamamoto K; Kimura D; Akbari M; Yuda M; Yui K
Parasitol Int; 2017 Jun; 66(3):227-235. PubMed ID: 28163249
[TBL] [Abstract][Full Text] [Related]
7. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria.
Oakley MS; Sahu BR; Lotspeich-Cole L; Solanki NR; Majam V; Pham PT; Banerjee R; Kozakai Y; Derrick SC; Kumar S; Morris SL
J Immunol; 2013 Nov; 191(9):4699-708. PubMed ID: 24078698
[TBL] [Abstract][Full Text] [Related]
8. Inducible Costimulator Expressing T Cells Promote Parasitic Growth During Blood Stage
Jogdand GM; Sengupta S; Bhattacharya G; Singh SK; Barik PK; Devadas S
Front Immunol; 2018; 9():1041. PubMed ID: 29892278
[TBL] [Abstract][Full Text] [Related]
9. Contribution of the Ly49E natural killer receptor in the immune response to Plasmodium berghei infection and control of hepatic parasite development.
Filtjens J; Foquet L; Taveirne S; Van Ammel E; Vanhees M; Van Acker A; Kerre T; Taghon T; Vandekerckhove B; Plum J; Van den Steen PE; Leclercq G
PLoS One; 2014; 9(1):e87463. PubMed ID: 24498110
[TBL] [Abstract][Full Text] [Related]
10. Memory CD8
Shaw TN; Haley MJ; Dookie RS; Godfrey JJ; Cheeseman AJ; Strangward P; Zeef LAH; Villegas-Mendez A; Couper KN
Immunology; 2021 Dec; 164(4):737-753. PubMed ID: 34407221
[TBL] [Abstract][Full Text] [Related]
11. Prevention of experimental cerebral malaria by Flt3 ligand during infection with Plasmodium berghei ANKA.
Tamura T; Kimura K; Yuda M; Yui K
Infect Immun; 2011 Oct; 79(10):3947-56. PubMed ID: 21807908
[TBL] [Abstract][Full Text] [Related]
12. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
13. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8
Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN
Front Immunol; 2019; 10():248. PubMed ID: 30846985
[TBL] [Abstract][Full Text] [Related]
14. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
15. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
Keswani T; Bhattacharyya A
Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
[TBL] [Abstract][Full Text] [Related]
16. IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malaria.
Guo J; McQuillan JA; Yau B; Tullo GS; Long CA; Bertolino P; Roediger B; Weninger W; Taylor GA; Hunt NH; Ball HJ; Mitchell AJ
Infect Immun; 2015 Apr; 83(4):1406-17. PubMed ID: 25644000
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C θ deficiency increases resistance of C57BL/6J mice to Plasmodium berghei infection-induced cerebral malaria.
Ohayon A; Golenser J; Sinay R; Tamir A; Altman A; Pollack Y; Isakov N
Infect Immun; 2010 Oct; 78(10):4195-205. PubMed ID: 20660606
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection.
Villegas-Mendez A; de Souza JB; Murungi L; Hafalla JC; Shaw TN; Greig R; Riley EM; Couper KN
J Immunol; 2011 Sep; 187(6):2885-97. PubMed ID: 21880980
[TBL] [Abstract][Full Text] [Related]
19. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.
Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z
Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352
[TBL] [Abstract][Full Text] [Related]
20. Eosinophils Suppress the Migration of T Cells Into the Brain of
Scheunemann JF; Reichwald JJ; Korir PJ; Kuehlwein JM; Jenster LM; Hammerschmidt-Kamper C; Lewis MD; Klocke K; Borsche M; Schwendt KE; Soun C; Thiebes S; Limmer A; Engel DR; Mueller AK; Hoerauf A; Hübner MP; Schumak B
Front Immunol; 2021; 12():711876. PubMed ID: 34659202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
